Mrs. Donna Donegan Morgan, L.I.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 45 Devon Rd, Newton, MA 02459 Phone: 617-965-2280 |
Natasha Kovalchuk Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 93 Union St # Sw.406, Newton, MA 02459 Phone: 617-965-4654 Fax: 617-527-4639 |
Linda Gershman, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Eden Ave, Newton, MA 02465 Phone: 617-243-0305 |
Catherine E Mitchell, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1600 Washington St, 318, Newton, MA 02465 Phone: 781-736-3730 |
Kathryn Gillroy Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 64 Eldredge St, Newton, MA 02458 Phone: 617-969-4925 |
Randy Lee Blume, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 38 Crafts St, Square Psychiatry, First Floor, Newton, MA 02458 Phone: 617-916-5069 Fax: 617-467-4073 |
Deborah Anne Krasnow Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 40 The Ledges Rd, Newton, MA 02459 Phone: 617-332-2243 |
Mrs. Penina Ilene Scharf, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 42 Glendale Rd, Newton, MA 02459 Phone: 617-504-0625 |
Ms. Sianna Lieb, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 90 Wells Ave, Newton, MA 02459 Phone: 617-969-6130 Fax: 617-928-1450 |
Abigail Osei-tutu, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 90 Wells Ave, Newton, MA 02459 Phone: 617-969-6130 Fax: 617-928-1450 |
Ms. Rebecca Leigh Weinstock, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 64 Eldredge St, Newton, MA 02458 Phone: 617-969-4925 |
Emily P Zylber, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 Langley Rd Ste 300, Newton, MA 02459 Phone: 617-699-8955 |
Mr. Stefano Carmine Navarroli, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 62 Prescott St, Newton, MA 02460 Phone: 617-969-9473 |
Mrs. Judith C Diamond, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 30 Bruce Lane, Newton, MA 02458 Phone: 617-965-3673 |
Ms. Kelly J Precious, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2014 Washington St, Newton Wellesley Hospital, Newton, MA 02462 Phone: 617-243-6000 Fax: 617-243-5669 |
Joseph Pasko Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 64 Eldredge St, Newton, MA 02458 Phone: 617-969-4925 |
Margot Trotter Davis, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 53 Langley Rd, Newton, MA 02459 Phone: 617-731-4899 |
Anne Weiss Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 53 Langley Rd Ste 340c, Newton, MA 02459 Phone: 617-244-9009 |
Charles Thompson, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2364 Washington St, Newton, MA 02462 Phone: 617-332-2047 Fax: 617-332-7341 |
Ms. Geri Reinhardt, LICSW (MSW) Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 650 Commonwealth Avenue, Newton, MA 02459 Phone: 617-964-1799 Fax: 617-969-0575 |
News Archive
New data from a Phase IIB clinical study of odanacatib, Merck & Co., Inc.'s oral, once-weekly investigational treatment for osteoporosis, showed that when stopping treatment after two years, the increases in lower back (lumbar spine) bone mineral density (BMD) were reversed over the next year, while BMD at the hip (femoral neck) remained above levels observed at the start of the study.
Valeant Pharmaceuticals International announced today that it has priced its previously announced offering of senior unsecured notes, which consists of $500 million of 6.75% Senior Notes due 2017 and $700 million of 7.00% Senior Notes due 2020 (collectively, the "Notes"). The $1.2 billion combined aggregate principal amount of the Notes was increased from the previously announced offering size of $1.0 billion. The offering is expected to close on or about September 28, 2010.
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.
Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.
A new study has identified the first common gene variants associated with an increased incidence of hypertension - a significant risk factor for heart attack, stroke and kidney failure.
› Verified 6 days ago